Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine
Posted on: Wednesday, 13 May 2009, 14:07 CDT
NIH Grant will also Fund Research of Advanced Technologies for Early Disease Detection
This research has been supported for the past six years by the National Institute of Allergy and Infectious Diseases (NIAID), a department of the NIH. The original grant, received in 2003, totaled
"We have made great progress over the past six years because of this grant. We now know that certain types of immune system cells are better for inducing immunity to the flu. We also know how to target them with molecules that we have developed at BRI," says Jacques Banchereau, Ph.D., director, Baylor Institute for Immunology Research. "With the new funding from the NIAID, we plan to further characterize our targeting molecules and continue to measure the immune response to the flu. This will prepare us for a clinical trial to test our new vaccine."
Additionally, BRI scientists have applied for a supplement to the grant that would allow them to specifically make a vaccine against swine flu. It would also fund studies researching how swine flu affects the immune systems of patients.
"There is serious concern throughout the world health communities about the dangers of emerging infectious diseases, like this new flu strain," says Dr. Banchereau. "Our flu research has focused on finding out how the immune system responds to the flu and on developing a new type of vaccine that will activate a strong protection against the flu."
To develop this vaccine, the researchers will target dendritic cells, key immune system cells that instruct the rest of the immune system to develop immunity against invading microbes.
Another project at BRI has expanded into a new Center for Personalized Medicine led by Damien Chaussabel, Ph.D., a scientist at BIIR. This new center is using microarray technology to measure the expression of over 45,000 genes from a single tube of a patient's blood. What they have found is that the immune system responds in unique ways to different kinds of diseases. This allows the researchers to identify a "biosignature," which can be used to diagnose diseases. This technology might one day be used in doctors' offices and hospitals to diagnose swine flu and other diseases.
"The work being carried out at BRI has the potential to transform the way that we treat patients and diagnose diseases, including those infected with swine flu," says
For more information about the Baylor Research Institute, visit www.BaylorHealth.com. For more information about BIIR, visit www.BIIR.org.
SOURCE Baylor Health Care System
Source: PR Newswire
Related Articles
- Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
- Institute for OneWorld Health Announces Strategic Advisory Board for Diarrheal Disease Program
- Roche and the Institute for OneWorld Health Announce Research Collaboration to Fight Neglected Diarrheal Diseases in Developing Countries
- New Cure for Deadly Visceral Leishmaniasis (Kala-Azar) Approved By Government of India; Institute for OneWorld Health and Gland Pharma Limited Achieve Critical Paromomycin Milestone
- Systemic Intervention for Public Health
- Institute for OneWorld Health Receives Multimillion Dollar Grant to Create Innovative and Sustainable Disease Control Program; $30M Gates Foundation Grant Aims to Greatly Reduce VL Deaths
- San Antonio OB/GYN Practice Goes Electronic; Institute for Women's Health Selects Electronic Medical Record By A4 Health Systems
- Hemispherx Biopharma Signs Research Agreement With Japanese National Institute of Infectious Disease; Ampligen(R) Sought As Adjuvant for Nasal Flu Vaccine
- National Institute of Mental Health Awards $3 Million Research Grant to PORTALS and Social Work Researchers From USC and UCLA
 |
 |
User Comments (0)
RSS Feeds